Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Biocon Ltd. Regulatory Filings 2021

Nov 11, 2021

61176_rns_2021-11-11_4a984843-4b24-4a41-9393-0daf1f0bfb30.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

==> picture [102 x 40] intentionally omitted <==

Biocon Limited 20th KM, Hosur Road Electronic City Bangalore 560 100, India T 91 80 2808 2808 F 91 80 2852 3423 CIN : L24234KA1978PLC003417

www.biocon.com

November 11, 2021

To
The Secretary
BSE Limited
Department of Corporate Services
Phiroze Jeejeebhoy Towers,
Dalal Street,Mumbai – 400 001
To
The Secretary
National Stock Exchange of India Limited
Corporate Communication Department
Exchange Plaza, Bandra Kurla Complex
Mumbai – 400 050
Scrip Code - 532523 Scrip Symbol - BIOCON

Dear Sir/Madam,

Sub: Meeting conducted with Institutional Investors/Research Analysts.

Ref: Revised Intimation under Regulation 30 (6) of SEBI Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015.

Pursuant to Regulation 30 (6) of the SEBI LODR Regulations, 2015, we hereby inform you that the following meeting was conducted with Institutional Investor / Research Analysts:

Date Name Type of meeting Location
November 10, 2021 ApaH Capital Management Limited Teleconference Bangalore
Myriad Asset Management Limited

We request you to kindly take above intimation on record.

Thanking You,

Yours faithfully,

For Biocon Limited

==> picture [72 x 32] intentionally omitted <==

==> picture [73 x 77] intentionally omitted <==


Mayank Verma Company Secretary and Compliance Officer